April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Effect of Systemic Hypertension and Dyslipidemia on the Relationship Between Serum Prorenin and Retinal Blood Flow in Type 2 Diabetes Patients
Author Affiliations & Notes
  • T. tani
    Ophthalmology, Asahikawa medical college, Asahikawa, Japan
  • T. Nagaoka
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • H. Yokota
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • A. Takahashi
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • K. Sogawa
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • T. Omae
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • S. Nakabayashi
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • I. Tanano
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • A. Ishibazawa
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • A. Yoshida
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • Footnotes
    Commercial Relationships  T. tani, None; T. Nagaoka, None; H. Yokota, None; A. Takahashi, None; K. Sogawa, None; T. Omae, None; S. Nakabayashi, None; I. Tanano, None; A. Ishibazawa, None; A. Yoshida, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5071. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. tani, T. Nagaoka, H. Yokota, A. Takahashi, K. Sogawa, T. Omae, S. Nakabayashi, I. Tanano, A. Ishibazawa, A. Yoshida; Effect of Systemic Hypertension and Dyslipidemia on the Relationship Between Serum Prorenin and Retinal Blood Flow in Type 2 Diabetes Patients. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5071.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the effect of systemic hypertension (HT) and dyslipidemia (DL) on the relationship between serum prorenin and retinal circulation in patients with type 2 diabetes mellitus with systemic HT and DL.

Methods: : One hundred forty-four patients with diabetes (59.1±10.7 years) (mean±SD) and 45 control subjects (61.0±10.0 years) were enrolled in this study. The patients with diabetes had no diabetic retinopathy (DR) (n=101) or background DR (n=43) and were divided into four groups: diabetes without DL and HT (DM only group, n=43), diabetes with DL (DL group, n=27), diabetes with HT (HT group, n=28), and diabetes with DL and HT (DL+HT group, n=46). The serum prorenin levels of all subjects were measured using the antibody activating direct kinetic assay. The retinal circulation, which includes retinal vessel diameter and blood velocity that are used to calculate the retinal blood flow, was measured by using a laser Doppler velocimetry system (CLBF Model 100; Canon, Tokyo, Japan). The serum prorenin levels and retinal circulation were compared among the groups.

Results: : The serum prorenin levels in the HT (p<0.05) and DL+HT groups (p<0.01) were significantly higher compared with the control group. The serum prorenin level were significantly correlated with the retinal vessel velocity only in the DL+HT group (p=0.0093, r=-0.3754).

Conclusions: : Our results showed an increased serum prorenin level in patients with type 2 diabetes and HT. The serum prorenin level was negatively correlated with vessel velocity in the DL+HT group, suggesting that serum prorenin may be associated with impaired retinal circulation in patients with type 2 diabetes with systemic risk factors of HT and DL, especially in early-phase DR.

Keywords: diabetic retinopathy • clinical (human) or epidemiologic studies: risk factor assessment • flow cytometry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×